Cargando…
P1324: EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430743/ http://dx.doi.org/10.1097/01.HS9.0000972184.83537.cc |
| _version_ | 1785091039555485696 |
|---|---|
| author | Zhu, Lidan Liu, Jia Gao, Shichun Wang, Lu Liu, Huanfeng Kong, Peiyan Chen, Ting Feng, Yimei Yao, Han Liu, Yuqing Zhao, Lu Gao, Lei Zhang, XI |
| author_facet | Zhu, Lidan Liu, Jia Gao, Shichun Wang, Lu Liu, Huanfeng Kong, Peiyan Chen, Ting Feng, Yimei Yao, Han Liu, Yuqing Zhao, Lu Gao, Lei Zhang, XI |
| author_sort | Zhu, Lidan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430743 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104307432023-08-17 P1324: EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA Zhu, Lidan Liu, Jia Gao, Shichun Wang, Lu Liu, Huanfeng Kong, Peiyan Chen, Ting Feng, Yimei Yao, Han Liu, Yuqing Zhao, Lu Gao, Lei Zhang, XI Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430743/ http://dx.doi.org/10.1097/01.HS9.0000972184.83537.cc Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhu, Lidan Liu, Jia Gao, Shichun Wang, Lu Liu, Huanfeng Kong, Peiyan Chen, Ting Feng, Yimei Yao, Han Liu, Yuqing Zhao, Lu Gao, Lei Zhang, XI P1324: EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA |
| title | P1324: EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA |
| title_full | P1324: EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA |
| title_fullStr | P1324: EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA |
| title_full_unstemmed | P1324: EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA |
| title_short | P1324: EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA |
| title_sort | p1324: efficacy and safety of dose-adjusted atg combined with cd25 antibody in the prevention of gvhd after haplo-hsct: clinical study data from a single center in china |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430743/ http://dx.doi.org/10.1097/01.HS9.0000972184.83537.cc |
| work_keys_str_mv | AT zhulidan p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT liujia p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT gaoshichun p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT wanglu p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT liuhuanfeng p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT kongpeiyan p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT chenting p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT fengyimei p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT yaohan p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT liuyuqing p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT zhaolu p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT gaolei p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina AT zhangxi p1324efficacyandsafetyofdoseadjustedatgcombinedwithcd25antibodyinthepreventionofgvhdafterhaplohsctclinicalstudydatafromasinglecenterinchina |